BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30059432)

  • 21. Simultaneous breast cancer and DLBCL lymphoma - role of PET/CT examination with 18F-FDG and 18F-FES.
    Hołody Ł; Kunikowska J; Braziewicz J
    Nucl Med Rev Cent East Eur; 2018; 21(2):113-114. PubMed ID: 29956818
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Integration of PET in DLBCL.
    Lewis KL; Trotman J
    Semin Hematol; 2023 Nov; 60(5):291-304. PubMed ID: 38326144
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG PET/CT Findings in Abdominal Fat Necrosis After Treatment for Lymphoma.
    Dubreuil J; Moreau A; Sarkozy C; Traverse-Glehen A; Skanjeti A; Salles G; Giammarile F
    Clin Nucl Med; 2016 May; 41(5):397-8. PubMed ID: 26825213
    [TBL] [Abstract][Full Text] [Related]  

  • 24.
    Ram-Wolff C; Vercellino L; Brice P; La Selva R; Bagot M
    Eur J Dermatol; 2017 Oct; 27(5):496-504. PubMed ID: 28721937
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unusual involvement of scalp and bilateral kidneys in an aggressive mediastinal diffuse large B cell lymphoma: documentation by FDG-PET imaging.
    Basu S; Ramani SK; Lad S
    Clin Nucl Med; 2009 Sep; 34(9):638-41. PubMed ID: 19692836
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 18F-FDG uptake and its clinical relevance in primary gastric lymphoma.
    Yi JH; Kim SJ; Choi JY; Ko YH; Kim BT; Kim WS
    Hematol Oncol; 2010 Jun; 28(2):57-61. PubMed ID: 19593742
    [TBL] [Abstract][Full Text] [Related]  

  • 27. F-18 FDG PET and Ga-67 scintigraphy in a case of fever of unknown origin with underlying cutaneous diffuse large B-Cell lymphoma.
    Hsieh HJ; Lin SH; Chu YK; Chang CP; Liu RS
    Clin Nucl Med; 2004 Dec; 29(12):859-60. PubMed ID: 15545909
    [No Abstract]   [Full Text] [Related]  

  • 28. Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma.
    Mylam KJ; Nielsen AL; Pedersen LM; Hutchings M
    PET Clin; 2014 Oct; 9(4):443-55, vi. PubMed ID: 26050946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. (18) F-FDG PET-CT and trephine biopsy assessment of bone marrow involvement in lymphoma.
    Ujjani CS; Hill EM; Wang H; Nassif S; Esposito G; Ozdemirli M; Cordova C; Cheson BD
    Br J Haematol; 2016 Aug; 174(3):410-6. PubMed ID: 27098364
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone marrow evaluation in initial staging of lymphoma: 18F-FDG PET/CT versus bone marrow biopsy.
    Cortés-Romera M; Sabaté-Llobera A; Mercadal-Vilchez S; Climent-Esteller F; Serrano-Maestro A; Gámez-Cenzano C; González-Barca E
    Clin Nucl Med; 2014 Jan; 39(1):e46-52. PubMed ID: 23640215
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FDG-PET for Early Response Assessment in Lymphomas: Part 2-Diffuse Large B-Cell Lymphoma, Use of Quantitative PET Evaluation.
    Cheson BD; Kostakoglu L
    Oncology (Williston Park); 2017 Jan; 31(1):71-76. PubMed ID: 28090627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Utility of 18F-fluorodeoxyglucose Positron-Emission Tomography/Computed Tomography in Cutaneous B-Cell Lymphoma.
    Feuerman H; Snast I; Amitay-Laish I; Bairey O; Barzilai A; Feinmesser M; Mimouni D; Even-Sapir E; Hodak E
    Isr Med Assoc J; 2019 Sep; 21(9):580-584. PubMed ID: 31542900
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Diffuse Large B-Cell Lymphoma: Prospective Multicenter Comparison of Early Interim FLT PET/CT versus FDG PET/CT with IHP, EORTC, Deauville, and PERCIST Criteria for Early Therapeutic Monitoring.
    Minamimoto R; Fayad L; Advani R; Vose J; Macapinlac H; Meza J; Hankins J; Mottaghy F; Juweid M; Quon A
    Radiology; 2016 Jul; 280(1):220-9. PubMed ID: 26854705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The value of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography for staging of primary extranodal head and neck lymphomas.
    Schrepfer T; Haerle SK; Strobel K; Schaefer N; Hälg RA; Huber GF
    Laryngoscope; 2010 May; 120(5):937-44. PubMed ID: 20422687
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of CT-Based Measurements into Surveillance PET/CT in Patients with Diffuse Large B Cell Lymphoma.
    Lavi N; Shapira G; Zilberlicht A; Benyamini N; Farbstein D; Dann EJ; Bar-Shalom R; Avivi I
    Isr Med Assoc J; 2016 Jul; 18(7):411-417. PubMed ID: 28471564
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Lymphoma involving the brain and adrenals: A chicken and egg situation.
    Zafar T; Hassan A; Siddiqui N; Bashir H
    J Pak Med Assoc; 2021 Feb; 71(2(B)):778. PubMed ID: 33941982
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of FDG-PET/CT in detecting lymphomatous bone marrow involvement in patients with newly diagnosed diffuse large B-cell lymphoma.
    Hong J; Lee Y; Park Y; Kim SG; Hwang KH; Park SH; Jeong J; Kim KH; Ahn JY; Park S; Park J; Lee JH
    Ann Hematol; 2012 May; 91(5):687-695. PubMed ID: 22008868
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of 18F-FDG PET/CT for cutaneous extranodal natural killer/T-cell lymphoma, nasal type.
    Liu C; Zhang Y; Zhang Y; Wang M; Liu R; Liu X; Hu S
    Nucl Med Commun; 2016 May; 37(5):446-52. PubMed ID: 26657218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Diagnostic value of FDG-PET in the detection of bone marrow involvement in patients with diffuse large B-cell lymphoma].
    Zhang X; Fan W; Lin XP
    Zhonghua Xue Ye Xue Za Zhi; 2008 Dec; 29(12):832-5. PubMed ID: 19176040
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diffuse Large B-Cell Lymphoma Recurring as Neurolymphomatosis on FDG PET/CT.
    Ganeshalingam R; Roach P; Schembri GP
    Clin Nucl Med; 2019 Feb; 44(2):145-147. PubMed ID: 30516683
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.